Concentrated pharma exposure delivered 31% returns over one year, while active healthcare management achieved 18%.
These two healthcare ETFs take fundamentally different approaches to investing, with meaningful differences in diversification, management strategy, and long-term return potential.
PINK offers broad active healthcare exposure with lower volatility, while FBT's concentrated biotech play delivered stronger 1-year returns but carries steeper drawdown risk.
Active management and a philanthropic mission set Simplify apart, though State Street's lower costs and stronger recent returns appeal to passive investors.
VanEck offers lower costs and higher dividends with a concentrated pharma focus, while Simplify provides broader healthcare exposure and donates profits to breast cancer research.
iShares offers lower fees and concentrated biotech exposure with stronger 1-year returns, while Simplify provides broader healthcare diversification and a higher dividend yield.
Vanguard offers broad exposure at 0.09% cost with 1.5% yield, while Simplify's active strategy returned 32.4% over one year but charges 0.51%.
This is the newest page. Registered accounts read further back.